Homsi J - Search Results

1

Melanoma of the anal canal: a case series.

Homsi J, Garrett C. Homsi J, et al. Dis Colon Rectum. 2007 Jul;50(7):1004-10. doi: 10.1007/s10350-007-0242-5. Dis Colon Rectum. 2007. PMID: 17468984

2

Cutaneous melanoma: prognostic factors.

Homsi J, Kashani-Sabet M, Messina JL, Daud A. Homsi J, et al. Cancer Control. 2005 Oct;12(4):223-9. doi: 10.1177/107327480501200403. Cancer Control. 2005. PMID: 16258493 Free article. Review.

3

Phase I trial of poly-L-glutamate camptothecin (CT-2106) administered weekly in patients with advanced solid malignancies.

Homsi J, Simon GR, Garrett CR, Springett G, De Conti R, Chiappori AA, Munster PN, Burton MK, Stromatt S, Allievi C, Angiuli P, Eisenfeld A, Sullivan DM, Daud AI. Homsi J, et al. Clin Cancer Res. 2007 Oct 1;13(19):5855-61. doi: 10.1158/1078-0432.CCR-06-2821. Clin Cancer Res. 2007. PMID: 17908979 Clinical Trial.

4

Hepatic arterial infusion of chemotherapy for hepatic metastases from colorectal cancer.

Homsi J, Garrett CR. Homsi J, et al. Cancer Control. 2006 Jan;13(1):42-7. doi: 10.1177/107327480601300106. Cancer Control. 2006. PMID: 16508625 Free article.

5

The Src signaling pathway: a potential target in melanoma and other malignancies.

Homsi J, Cubitt C, Daud A. Homsi J, et al. Expert Opin Ther Targets. 2007 Jan;11(1):91-100. doi: 10.1517/14728222.11.1.91. Expert Opin Ther Targets. 2007. PMID: 17150037 Review.

6

Src activation in melanoma and Src inhibitors as therapeutic agents in melanoma.

Homsi J, Cubitt CL, Zhang S, Munster PN, Yu H, Sullivan DM, Jove R, Messina JL, Daud AI. Homsi J, et al. Melanoma Res. 2009 Jun;19(3):167-75. doi: 10.1097/CMR.0b013e328304974c. Melanoma Res. 2009. PMID: 19434004

7

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in patients with metastatic uveal melanoma.

Homsi J, Bedikian AY, Papadopoulos NE, Kim KB, Hwu WJ, Mahoney SL, Hwu P. Homsi J, et al. Melanoma Res. 2010 Dec;20(6):507-10. doi: 10.1097/CMR.0b013e3283403ce9. Melanoma Res. 2010. PMID: 20881508 Clinical Trial.

8

Phase 2 open-label study of weekly docosahexaenoic acid-paclitaxel in cutaneous and mucosal metastatic melanoma patients.

Homsi J, Bedikian AY, Kim KB, Papadopoulos NE, Hwu WJ, Mahoney SL, Hwu P. Homsi J, et al. Melanoma Res. 2009 Aug;19(4):238-42. doi: 10.1097/CMR.0b013e32832a1e2f. Melanoma Res. 2009. PMID: 19521262 Clinical Trial.

9

Predictive factors for the development of brain metastasis in advanced unresectable metastatic melanoma.

Bedikian AY, Wei C, Detry M, Kim KB, Papadopoulos NE, Hwu WJ, Homsi J, Davies M, McIntyre S, Hwu P. Bedikian AY, et al. Among authors: homsi j. Am J Clin Oncol. 2011 Dec;34(6):603-10. doi: 10.1097/COC.0b013e3181f9456a. Am J Clin Oncol. 2011. PMID: 21150567

10

Impact of clinical and pathologic features on tumor-infiltrating lymphocyte expansion from surgically excised melanoma metastases for adoptive T-cell therapy.

Joseph RW, Peddareddigari VR, Liu P, Miller PW, Overwijk WW, Bekele NB, Ross MI, Lee JE, Gershenwald JE, Lucci A, Prieto VG, McMannis JD, Papadopoulos N, Kim K, Homsi J, Bedikian A, Hwu WJ, Hwu P, Radvanyi LG. Joseph RW, et al. Among authors: homsi j. Clin Cancer Res. 2011 Jul 15;17(14):4882-91. doi: 10.1158/1078-0432.CCR-10-2769. Epub 2011 Jun 1. Clin Cancer Res. 2011. PMID: 21632855 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

79 results

Search Page